In	O
both	O
species	O
(	B-Drug_n
-	O
)	I-Drug_n
-	O
NANM	I-Drug_n
but	O
not	O
(	O
+	B-Drug_n
)	O
-	O
NANM	I-Drug_n
antagonized	O
the	O
rate	O
-	O
decreasing	O
effects	O
of	O
morphine	B-Drug
on	O
FI	O
and	O
FR	O
responding	O
.	O
      
In	O
conclusion	O
we	O
demonstrated	O
an	O
isolated	O
effect	O
of	O
calcium	B-Drug
(	O
as	O
chloride	O
)	O
on	O
absorption	O
of	O
9	O
mg	O
of	O
iron	O
provided	O
as	O
nonheme	B-Drug
(	O
as	O
sulfate	O
)	O
and	O
heme	B-Drug
(	O
as	O
CRBC	O
)	O
iron	I-Drug
.	O
      
The	O
distribution	O
of	O
renal	O
replacement	O
therapies	O
were	O
:	O
9	O
peritoneal	O
dialysis	O
9	O
conventional	O
hemodialysis	O
and	O
9	O
nocturnal	O
hemodialysis	O
.	O
      
cases	O
occurred	O
between	O
the	O
9th	O
and	O
the	O
9th	O
day	O
of	O
treatment	O
.	O
      
For	O
conditioned	O
place	O
preference	O
subjects	O
were	O
conditioned	O
for	O
9	O
consecutive	O
days	O
(	O
P9	O
-	O
9	O
)	O
with	O
amphetamine	B-Drug
(	O
9	O
mg	O
/	O
kg	O
)	O
or	O
saline	O
and	O
a	O
drug	O
-	O
free	O
preference	O
test	O
was	O
conducted	O
at	O
P9	O
.	O

      
